Your browser doesn't support javascript.
loading
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors.
Baird, Richard D; Kitzen, Jos; Clarke, Paul A; Planting, Andre; Reade, Sarah; Reid, Alison; Welsh, Lyndsey; López Lázaro, Luis; de las Heras, Begona; Judson, Ian R; Kaye, Stan B; Eskens, Ferry; Workman, Paul; deBono, Johann S; Verweij, Jaap.
Afiliação
  • Baird RD; Section of Medicine, Royal Marsden Hospital and Institute of Cancer Research, Downs Road, Sutton, Surrey, United Kingdom.
Mol Cancer Ther ; 8(6): 1430-7, 2009 Jun.
Article em En | MEDLINE | ID: mdl-19509256

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bivalves / Alcanos / Lipídeos / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bivalves / Alcanos / Lipídeos / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2009 Tipo de documento: Article